Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic phenotype stratification identifies patients at high risk of poor glycemic control in type 2 diabetes mellitus: Insights into hepatic metabolic dysfunction.

BMC endocrine disorders - 26 Jun 2026

Qi Wenxuan, Zhao Wenhua, Chen Li

Abstract excerpt

BACKGROUND: To characterize metabolic dphenotypes based on integrated hepatic and metabolic indicators and evaluate their association with poor glycemic control in patients with Type 2 diabetes mellitus (T2DM). METHODS: A total of 320 patients with T2DM were retrospectively enrolled. Data on liver function, blood lipids, insulin resistance, and indicators related to fatty liver were collected. Unsupervised...

Read the complete abstract on PubMed

Topics

Humans
Diabetes Mellitus, Type 2
Female
Male
Middle Aged
Retrospective Studies
Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Glycemic Control

Risk Factors

Glycated Hemoglobin

Blood Glucose

Insulin Resistance

Biomarkers

Prognosis

Liver

Follow-Up Studies

Aged

Source

Open in PubMed Open full text

Identifiers

PMID: 42363156
DOI: 10.1186/s12902-026-02365-0
PMCID: PMC13591677

Genes

TG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic phenotype stratification identifies patients at high risk of poor glycemic control in type 2 diabetes mellitus: Insights into hepatic metabolic dysfunction.PMID 42363156Read ↗

Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetesSemantic proximity Read ↗

Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes.Semantic proximity Read ↗

Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine.Semantic proximity Read ↗

[Precise clinical classification of metabolic associated fatty liver disease].Semantic proximity Read ↗

Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.Semantic proximity Read ↗

Advances in Metabolomics: A Comprehensive Review of Type 2 Diabetes and Cardiovascular Disease InteractionsSemantic proximity Read ↗

Metabolic dysfunction-associated steatotic liver disease as a systemic disorder: extrahepatic manifestations and the need for data-driven phenotyping.Semantic proximity Read ↗

Phenotypic patterns of metabolic dysfunction‐associated steatotic liver disease in type 2 diabetes: The impact of insulinSemantic proximity Read ↗

Association of non-invasive liver-related scores with cardiovascular disease and a four-domain cardiovascular-renal-hepatic-metabolic phenotype in patients with type 2 diabetes mellitus and MASLD.Semantic proximity Read ↗

Enriched Metabolic Phenotyping Refines Phenotypic Resolution of Type 2 Diabetes.Semantic proximity Read ↗

Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study.Semantic proximity Read ↗

Heterogeneity in risk and potential pathogenic associations of NAFLD among distinct prediabetic phenotypes in young and middle-aged adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.